Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Forrest SJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Forrest SJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu., Gupta H; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Li YY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doan D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Al-Ibraheemi A; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Alexandrescu S; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mullen EA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wright KD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kumari P; Dana-Farber Cancer Institute, Boston, MA, USA., Mazor T; Dana-Farber Cancer Institute, Boston, MA, USA., Ligon KL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Shivdasani P; Brigham and Women's Hospital, Boston, MA, USA., Manam M; Boston Children's Hospital, Boston, MA, USA., MacConaill LE; Brigham and Women's Hospital, Boston, MA, USA., Ceca E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Benich SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA, USA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA., Guidry Auvil JM; National Cancer Institute, Bethesda, MD, USA., Cerami E; Dana-Farber Cancer Institute, Boston, MA, USA., Rollins BJ; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Meyerson ML; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lindeman NI; Weill Cornell Medical College, New York, NY, USA., Johnson BE; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Cherniack AD; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Church AJ; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 22; Vol. 15 (1), pp. 7218. Date of Electronic Publication: 2024 Aug 22.
Autor:
Forrest SJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu., Gupta H; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Li YY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doan D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Al-Ibraheemi A; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Alexandrescu S; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mullen EA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wright KD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kumari P; Dana-Farber Cancer Institute, Boston, MA, USA., Mazor T; Dana-Farber Cancer Institute, Boston, MA, USA., Ligon KL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Shivdasani P; Brigham and Women's Hospital, Boston, MA, USA., Manam M; Boston Children's Hospital, Boston, MA, USA., MacConaill LE; Brigham and Women's Hospital, Boston, MA, USA., Ceca E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Benich SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA, USA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA., Guidry Auvil JM; National Cancer Institute, Bethesda, MD, USA., Cerami E; Dana-Farber Cancer Institute, Boston, MA, USA., Rollins BJ; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Meyerson ML; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lindeman NI; Weill Cornell Medical College, New York, NY, USA., Johnson BE; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Cherniack AD; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Church AJ; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 11; Vol. 15 (1), pp. 5837. Date of Electronic Publication: 2024 Jul 11.
Autor:
Groves A; Division of Pediatric Hematology/Oncology, University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, USA., Ward A; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Li YY; Dana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Lazo de la Vega L; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Nag A; Dana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Forrest SJ; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Gupta HV; Dana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Thorner AR; Dana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Meyerson M; Dana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Kamihara J; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Cherniack AD; Dana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA., Janeway KA; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Nov; Vol. 70 (11), pp. e30643. Date of Electronic Publication: 2023 Aug 19.
Autor:
Marinoff AE; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA.; Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital, San Francisco, CA., Spurr LF; Broad Institute of Harvard and MIT, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Pritzker School of Medicine, Biological Sciences Division, The University of Chicago, Chicago, IL., Fong C; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Li YY; Harvard Medical School, Boston, MA.; Broad Institute of Harvard and MIT, Boston, MA., Forrest SJ; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA., Ward A; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Doan D; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Corson L; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Mauguen A; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Pinto N; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle, WA., Maese L; University of Utah, Huntsman Cancer Institute, and Primary Children's Hospital, Salt Lake City, UT., Colace S; Pediatric Hematology/Oncology/Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH., Macy ME; Department of Pediatric Hematology/Oncology, University of Colorado and The Center for Cancer and Blood Disorders, Colorado Children's Hospital, Denver, CO., Kim A; Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC., Sabnis AJ; Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital, San Francisco, CA., Applebaum MA; Department of Pediatrics, University of Chicago, Chicago, IL., Laetsch TW; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA., Glade-Bender J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Weiser DA; Department of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, New York, NY., Anderson M; Harvard Medical School, Boston, MA.; Department of Orthopedic Surgery, Boston Children's Hospital, Boston, MA., Crompton BD; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA., Meyers P; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Zehir A; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., MacConaill L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Lindeman N; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Nowak JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Ladanyi M; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY., Church AJ; Harvard Medical School, Boston, MA.; Department of Pathology, Boston Children's Hospital, Boston, MA., Cherniack AD; Harvard Medical School, Boston, MA.; Broad Institute of Harvard and MIT, Boston, MA., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Janeway KA; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2023 Mar; Vol. 7, pp. e2200334.
Autor:
Lazo De La Vega L; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Comeau H; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Sallan S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Al-Ibraheemi A; Boston Children's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Gupta H; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Li YY; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Tsai HK; Boston Children's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Kang W; University of Chicago, Chicago, IL., Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Church AJ; Boston Children's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Kim A; Children's National Hospital, Washington, DC.; George Washington University School of Medicine and Health Sciences, Washington, DC., Pinto NR; Seattle Children's Hospital, Seattle, WA.; University of Washington, Seattle, WA., Macy ME; Children's Hospital of Colorado, Aurora, CO.; University of Colorado School of Medicine, Aurora, CO., Maese LD; Primary Children's Hospital, Salt Lake City, UT.; University of Utah Huntsman Cancer Institute, Salt Lake City, UT., Sabnis AJ; Department of Pediatrics, University of California, San Francisco, San Francisco, CA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA., Cherniack AD; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lindeman NI; Harvard Medical School, Boston, MA.; Brigham & Women's Hospital, Boston, MA., Anderson ME; Harvard Medical School, Boston, MA.; Orthopedic Center, Boston Children's Hospital, Boston, MA., Cooney TM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA., Yeo KK; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA., Reaman GH; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA., Johnson BE; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brigham & Women's Hospital, Boston, MA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA., Forrest SJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Nov; Vol. 6, pp. e2200390.
Autor:
Church AJ; Boston Children's Hospital, Boston, MA, USA. Alanna.Church@childrens.harvard.edu.; Harvard Medical School, Boston, MA, USA. Alanna.Church@childrens.harvard.edu., Corson LB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sema4, Stamford, CT, USA., Kao PC; Boston Children's Hospital, Boston, MA, USA., Imamovic-Tuco A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Reidy D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; University of Connecticut School of Medicine, Farmington, CT, USA., Doan D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; University of Massachusetts Medical School, Worcester, MA, USA., Kang W; University of Chicago, Chicago, IL, USA., Pinto N; Seattle Children's Hospital, Seattle, WA, USA.; University of Washington, Seattle, WA, USA., Maese L; Primary Children's Hospital, Salt Lake City, UT, USA.; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Laetsch TW; University of Texas Southwestern Medical Center, Dallas, TX, USA.; Children's Hospital of Philadelphia, Philadelphia, PA, USA.; University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Kim A; Children's National Hospital, Washington, DC, USA.; George Washington University School of Medicine and Health Sciences, Washington, DC, USA., Colace SI; Nationwide Children's Hospital, Columbus, OH, USA.; Ohio State University College of Medicine, Columbus, OH, USA., Macy ME; Children's Hospital of Colorado, Aurora, CO, USA.; University of Colorado School of Medicine, Aurora, CO, USA., Applebaum MA; University of Chicago, Chicago, IL, USA.; Comer Children's Hospital, Chicago, IL, USA., Bagatell R; Children's Hospital of Philadelphia, Philadelphia, PA, USA.; University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Sabnis AJ; University of California San Francisco Benioff Children's Hospital, San Francisco, CA, USA., Weiser DA; Children's Hospital at Montefiore, New York, NY, USA.; Albert Einstein College of Medicine, New York, NY, USA., Glade-Bender JL; Columbia University Irving Medical Center, New York, NY, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Homans AC; University of Vermont Medical Center, Burlington, VT, USA.; University of Vermont, Burlington, VT, USA., Hipps J; University of North Carolina Medical Center, Chapel Hill, NC, USA.; University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, NC, USA., Harris H; Boston Children's Hospital, Boston, MA, USA., Manning D; Brigham and Women's Hospital, Boston, MA, USA., Al-Ibraheemi A; Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Li Y; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gupta H; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Cherniack AD; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lo YC; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Mayo Clinic, Rochester, MN, USA., Strand GR; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Loyola University, Chicago, IL, USA., Lee LA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Children's Hospital of Philadelphia, Philadelphia, PA, USA., Pinches RS; Boston Children's Hospital, Boston, MA, USA.; Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA., Lazo De La Vega L; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Harden MV; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lennon NJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Choi S; University of Chicago, Chicago, IL, USA., Comeau H; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Harris MH; Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Forrest SJ; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Clinton CM; Boston Children's Hospital, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Crompton BD; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Kamihara J; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., MacConaill LE; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Volchenboum SL; University of Chicago, Chicago, IL, USA., Lindeman NI; Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Van Allen E; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., DuBois SG; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., London WB; Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Janeway KA; Harvard Medical School, Boston, MA, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Publikováno v:
Nature medicine [Nat Med] 2022 Aug; Vol. 28 (8), pp. 1581-1589. Date of Electronic Publication: 2022 Jun 23.
Autor:
Forrest SJ; School of Psychology., Siegert RJ; School of Clinical Sciences., Krägeloh CU; School of Clinical Sciences., Landon J; School of Clinical Sciences., Medvedev ON; School of Psychology.
Publikováno v:
Psychological assessment [Psychol Assess] 2021 Nov; Vol. 33 (11), pp. 1080-1088. Date of Electronic Publication: 2021 Aug 16.
Autor:
Pinches RS; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Clinton CM; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Ward A; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Meyer SC; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Wake Forest School of Medicine, Winston-Salem, North Carolina., Al-Ibraheemi A; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Forrest SJ; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Strand GR; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Emily Couric Clinical Cancer Center, University of Virginia, Charlottesville, Virginia., Detert H; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Foundation Medicine Inc., Cambridge, Massachusetts., Piche-Schulman A; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.; Department of Pathology, Lahey Hospital and Medical Center, Burlington, Massachusetts., Gill K; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Restrepo T; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Tavares Proulx R; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.; Department of Pathology, Community College of Rhode Island, Providence, Rhode Island., Perez-Atayde AR; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Vargas SO; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Shaikh R; Department of Radiology, Boston Children's Hospital, Boston, Massachusetts., Weldon C; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Department of Surgery, Boston Children's Hospital, Boston, Massachusetts.; Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts., Alexandrescu S; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Hong AL; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia., O'Neill AF; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Hollowell M; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Harris MH; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Janeway KA; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts., Crompton BD; Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Church AJ; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Sep; Vol. 67 (9), pp. e28326. Date of Electronic Publication: 2020 Jul 15.